Literature DB >> 5298036

Epidemiological significance of repeated infections with homologous and heterologous strains and species of Plasmodium.

G M Jeffery.   

Abstract

During many years of experience with the use of induced malaria for the therapy of neurosyphilis, it has been possible to observe the course of malarial infections in patients with known previous history of infection by the same and different strains and species of Plasmodium. This report presents the effect of prior infection on subsequent infection in regard to immune response of the host, clinical symptoms, parasitaemia, transmissibility and chemotherapeutic measures. These studies have shown that in no case was it impossible to induce additional infections in patients. However, in all homologous-species reinoculations, there were significant modifications of the infections, which were enhanced if both exposures were to the same strain. Variable results (ranging from no apparent effect to a fairly substantial modification) were seen after reinoculation of patients with a heterologous species of Plasmodium.The use of immunofluorescent methods may provide a clearer understanding of the mechanism of partial immunity as it affects reinfection. The relationship of this partial immunity to the epidemiology and chemotherapy of the disease in endemic areas is of importance, in that these infections in semi-immune persons provide a continuing and unapparent source of reinfection of the community.

Entities:  

Mesh:

Year:  1966        PMID: 5298036      PMCID: PMC2476277     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  7 in total

1.  The inoculation of semi-immune Africans with sporozoites of Laverania falcipara (Plasmodium falciparum) in Liberia.

Authors:  R S BRAY; A E GUNDERS; R W BURGESS; J B FREEMAN; E ETZEL; C GUTTUSO; B COLUSSA
Journal:  Riv Malariol       Date:  1962-12

2.  FLUORESCENT ANTIBODY STUDIES IN HUMAN MALARIA. II. DEVELOPMENT AND PERSISTENCE OF ANTIBODIES TO PLASMODIUM FALCIPARUM.

Authors:  W E COLLINS; G M JEFFERY; J C SKINNER
Journal:  Am J Trop Med Hyg       Date:  1964-03       Impact factor: 2.345

3.  FLUORESCENT ANTIBODY STUDIES IN HUMAN MALARIA.I. DEVELOPMENT OF ANTIBODIES TO PLASMODIUM MALARIAE.

Authors:  W E COLLINS; G M JEFFERY; J C SKINNER
Journal:  Am J Trop Med Hyg       Date:  1964-01       Impact factor: 2.345

4.  A LONGITUDINAL LONGITUDINAL SURVEY OF NATURAL MALARIA INFECTION IN A GROUP OF WEST AFRICAN ADULTS. I.

Authors:  L J BRUCE-CHWATT
Journal:  West Afr Med J       Date:  1963-08

Review 5.  A LONGITUDINAL SURVEY OF NATURAL MALARIA INFECTION IN A GROUP OF WEST AFRICAN ADULTS.

Authors:  L J BRUCE-CHWATT
Journal:  West Afr Med J       Date:  1963-10

6.  Clinical, chemotherapeutic and immunological studies on induced malaria.

Authors:  G COVELL; W D NICOL
Journal:  Br Med Bull       Date:  1951       Impact factor: 4.291

7.  FLUORESCENT ANTIBODY STUDIES IN HUMAN MALARIA. 3. DEVELOPMENT OF ANTIBODIES TO PLASMODIUM FALCIPARUM IN SEMI-IMMUNE PATIENTS.

Authors:  W E COLLINS; G M JEFFERY; J C SKINNER
Journal:  Am J Trop Med Hyg       Date:  1964-11       Impact factor: 2.345

  7 in total
  45 in total

1.  Mixed strain infections and strain-specific protective immunity in the rodent malaria parasite Plasmodium chabaudi chabaudi in mice.

Authors:  Sandra Cheesman; Ahmed Raza; Richard Carter
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

2.  Longitudinal study of Plasmodium falciparum polymorphic antigens in a malaria-endemic population.

Authors:  D J Conway; B M Greenwood; J S McBride
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

Review 3.  Why do we need to know more about mixed Plasmodium species infections in humans?

Authors:  Peter A Zimmerman; Rajeev K Mehlotra; Laurin J Kasehagen; James W Kazura
Journal:  Trends Parasitol       Date:  2004-09

4.  Roles of conserved and allelic regions of the major merozoite surface protein (gp195) in immunity against Plasmodium falciparum.

Authors:  G S Hui; A Hashimoto; S P Chang
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

Review 5.  Cross-species immunity in malaria vaccine development: two, three, or even four for the price of one?

Authors:  Bruno Douradinha; Maria M Mota; Adrian J F Luty; Robert W Sauerwein
Journal:  Infect Immun       Date:  2007-12-03       Impact factor: 3.441

6.  Serological malaria surveys in Nigeria.

Authors:  A Voller; L J Bruce-Chwatt
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

Review 7.  Chemical Attenuation in the Development of a Whole-Organism Malaria Vaccine.

Authors:  Amber I Raja; Danielle I Stanisic; Michael F Good
Journal:  Infect Immun       Date:  2017-06-20       Impact factor: 3.441

8.  Malaria vaccine development.

Authors:  R D Powell
Journal:  Bull World Health Organ       Date:  1979       Impact factor: 9.408

9.  Serological relationship of tumor necrosis factor-inducing exoantigens of Plasmodium falciparum and Plasmodium vivax.

Authors:  C A Bate; J Taverne; N D Karunaweera; K N Mendis; D Kwiatkowski; J H Playfair
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

10.  Stage-specific and species-specific antigens of Plasmodium vivax and Plasmodium ovale defined by monoclonal antibodies.

Authors:  P M Andrysiak; W E Collins; G H Campbell
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.